rarely if ever short a biotech. Haven't looked recently but they were burning through what cash they had. As I recall they had to borrow something like $20 million as their last financing which tells me they couldn't get any interested equity investors. Should be interesting to see what cash is on hand...
“A bank would never get away with what the Department of Education is doing.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.